Violations & penalties: what happens after a breach/review?

Program Instant Funding One Phase Two Phase
Severity Critical

TL;DR

Challenge breaches are typically instant fail. Funded/Instant Funding can also be terminated, reward denied, or (for some violations like news trading without the add-on) your split can be permanently reduced on that account.

How it works

There are two pathways:

  1. Hard breach (objective rule break)
  • Challenge: hard breach = fail.
  • Funded/Instant Funding: hard breach = termination / breach outcome per program rules.
  1. Review (behavior / integrity / abuse flags)
  • PropXP can examine trades and decide whether behavior falls under forbidden practices, and take action (including but not limited to removing trades from history / not counting results / termination / reducing leverage / reducing profit split.)
  • Example of review-based enforcement: “malicious gap” behavior can lead to warning, fail, or reward denial.

Common gotchas

  • Funded news violation can have a lasting consequence: rule breach can permanently reduce your reward split on that funded account.
  • Requesting a reward means stop trading until processed (don’t self-sabotage).
  • If your “edge” is exploiting platform mechanics (feeds/latency/glitches), PropXP treats it as abuse, not skill.
  • Reviews aren’t personal. They’re “is this fair + replicable + not manipulated.”

Example

On a funded account you violate the funded news restriction window. You might get to keep the account, but your future reward split on that account can be permanently reduced. (Don’t “news gamble” the account for one spicy candle.)

Didn't find the answer?

Our customer support run by human is available knowledge and read to help.
Pick their brain and find out what you need!

Ready to Earn
Performance Rewards?

  • Static drawdown
  • Up to $400,000 in PropXP accounts
  • Instant Funding available
Performance Rewards
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.